Table 1.
Stable RNPs Identified by DIF-FRAC
| Gene Names | Complex Name | Function | Soluble without RNA?a | Disease Links | CORUM/hu.MAPb | rna.MAP ID | DIF-FRAC Plot | RNP Classc | References |
|---|---|---|---|---|---|---|---|---|---|
| CLASP1 | N/A | microtubule binding | yes | N/A | no/yes | 3807 | apo-stable | Efimov et al., 2007 | |
| CLASP2 | microtubule dynamics | ||||||||
| DAXX | DAXX-TP53 complex | transcription repression | yes | pancreatic neuroendocrine tumors | yes/no | 4518 | apo-stable | Zhao et al., 2004 | |
| TP53 | glioblastoma multiforme | Dyer et al., 2017 | |||||||
| adrenocortical tumors | |||||||||
| DRG1 | Drg1/Dfrp1 complex | microtubule binding | yes | lung adenocarcinoma | no/no | 4096 | apo-stable | Lu et al., 2016 | |
| ZC3H15 | microtubule polymerase | Schellhaus et al., 2017 | |||||||
| GTPase | Ishikawa et al., 2009 | ||||||||
| BOD1L1 | SET1A/SET1B complexes | histone methyltransferase | yes | Fanconi anemia | yes/yes | 2005, 3307 | apo-stable | Vedadi et al., 2017 | |
| SETD1A | transcription regulation | mixed-lineage leukemia | Higgs et al., 2015 | ||||||
| CXXC1*,d | Brown et al., 2017 | ||||||||
| ASH2L | |||||||||
| RBBP5 | |||||||||
| WDR5 | |||||||||
| NIPSNAP1* | N/A | vesicular transport | no | inflammatory pain | no/yes | 5822 | apo-stable | Okuda-Ashitaka et al., 2012 | |
| NIPSNAP2* | Yamamoto et al., 2017 | ||||||||
| RPA1 | replication protein A complex | single-stranded DNA binding | yes | Werner syndrome | yes/yes | 3204 | apo-stable | Machwe et al., 2011 | |
| RPA2* | DNA metabolism | Fan and Pavletich, 2012 | |||||||
| RPA3*,d | |||||||||
| FLII | FLII-LRRFIP1 complex | transcriptional activation | yes | prostate cancer | no/yes | 3626 | apo-stable | Wilson et al., 1998 | |
| LRRFIP1 | actin binding | Wang et al., 2016 | |||||||
| BAZ1A* | WCRF complex | chromatin remodeling | No | intellectual disability | yes/no | 2105 | compositional | Bochar et al., 2000 | |
| SMARCA5 | Zaghlool et al., 2016 | ||||||||
| MICU1*,d | MICU1-MICU2 heterodimer | calcium ion transport | yes | myopathy with extrapyramidal signs | yes/yes | 4318 | structural | Logan et al., 2014 | |
| MICU2*,d | |||||||||
| NOC4L | N/A | ribosome processing and biogenesis | no | recurrent pregnancy loss | no/yes | 4220 | structural | Suzuki et al., 2018 | |
| NOP14 | |||||||||
| SFPQ | PSF-p54(nrb) complex | splicing factor | yes | intellectual disability | yes/yes | 327 | apo-stable | Bladen et al., 2005 | |
| NONO | DNA recombination | Mircsof et al., 2015 | |||||||
| RRP12 | N/A | rRNA processing | no | N/A | no/yes | 5795 | structural | Zemp et al., 2009 | |
| RIOK2 | |||||||||
| H1FX | |||||||||
| SAP18 | N/A | SAP18 is involved in RNA processing and splicing | no | N/A | no/yes | 6027 | structural | Davis et al., 2010 | |
| NKTR | |||||||||
| CCDC9 | NKTR is involved in protein peptidyl-prolyl isomerization | ||||||||
| LARP4 | N/A | translation regulation | yes | N/A | no/yes | 3327 | apo-stable | Yang et al., 2011 | |
| LARP4B | Schäffler et al., 2010 | ||||||||
| XRCC5 | Ku antigen complex | DNA damage and repair | yes | systemic lupus erythematosus | yes/no | 2930 | apo-stable | Spagnolo et al., 2006 | |
| XRCC6 | |||||||||
| SAMM50*,d | N/A | protein transport | yes | N/A | no/yes | 1450 | apo-stable | ||
| MTX3*,d | |||||||||
| MTX2* | |||||||||
| SLC25A5 | prohibitin | apoptosis | yes | N/A | yes/no | 204 | apo-stable | Kasashima et al., 2006 | |
| VDAC2 | |||||||||
| PHB | |||||||||
| HAX1* | |||||||||
| PHB2* | |||||||||
| TPP2 | tripeptidyl-peptidase II | serine protease | yes | muscle wasting | yes/no | apo-stable | Schönegge et al., 2012 | ||
| obesity | Rockel et al., 2012 | ||||||||
| cancer |
Previously unreported RNA-associated proteins identified by DIF-FRAC (see Table S1).
Insolubility in the absence of RNA is inferred by an increase in apparent molecular weight of the complex upon RNA digestion or a complete disappearance of signal. This is consistent with the RNP’s being solubilized by RNA, as suggested by Maharana et al. (2018).
Evidence for all or some protein complex subunits interacting in CORUM or hu.MAP.
RNP classes apo-stable, structural, and compositional, as described in Figure 4.
Previously unreported RNA-associated proteins that are above the 5% FDR cutoff.